Consensus HCA Healthcare, Inc.

Equities

HCA

US40412C1018

Market Closed - Nyse Other stock markets 04:00:02 2024-05-31 pm EDT			5-day change	1st Jan Change
339.8 ^USD	+1.39%		+6.60%	+25.52%

May. 31	Goldman Sachs Adjusts Price Target on HCA Healthcare to $340 From $311	MT
May. 30	Transcript : HCA Healthcare, Inc. Presents at Bernstein?s 40th Annual Strategic Decisions Conference, May-30-2024 11:00 AM

Evolution of the average Target Price on HCA Healthcare, Inc.

Price target over the last 5 years

History of analyst recommendation changes

5f486962ee325e0ad0e40237.1w1VY1diCnezWZySd8qxAGVi4wsL16wzVINeCroKObA.hHsvNGFPXQOLEtnLIv_lQS0Fi2Nf7vNiDvkWZtFvTOavXi0WJDRMIdAgyQ~7a6535ef16af1b31e4027e7d835ce36d

Analyst Recommendations on HCA Healthcare, Inc.

Goldman Sachs Adjusts Price Target on HCA Healthcare to $340 From $311	May. 31	MT
JPMorgan Adjusts Price Target on HCA Healthcare to $332 From $327	May. 30	MT
Baird Initiates HCA Healthcare With Outperform Rating, $396 Price Target	May. 30	MT
UBS Raises HCA Healthcare Price Target to $377 From $363, Maintains Buy Rating	May. 20	MT
DBS Bank Initiates HCA Healthcare at Buy Rating With $370 Price Target	May. 14	MT
Hca Healthcare Insider Sold Shares Worth $516,450, According to a Recent SEC Filing	May. 13	MT
Hca Healthcare Insider Sold Shares Worth $1,999,825, According to a Recent SEC Filing	May. 13	MT
Hca Healthcare Insider Sold Shares Worth $494,400, According to a Recent SEC Filing	May. 08	MT
TD Cowen Adjusts Price Target on HCA Healthcare to $360 From $371	Apr. 30	MT
Leerink Partners Adjusts Price Target on HCA Healthcare to $367 From $354	Apr. 29	MT
UBS Adjusts HCA Healthcare Price Target to $363 From $348, Maintains Buy Rating	Apr. 29	MT
RBC Capital Adjusts Price Target on HCA Healthcare to $329 From $322	Apr. 29	MT
Oppenheimer Adjusts HCA Healthcare Price Target to $345 From $330, Maintains Outperform Rating	Apr. 29	MT
Barclays Adjusts HCA Healthcare's Price Target to $367 From $356, Keeps Overweight Rating	Apr. 29	MT
Mizuho Adjusts Price Target on HCA Healthcare to $370 From $345	Apr. 22	MT
Truist Securities Adjusts Price Target on HCA Healthcare to $375 From $345	Apr. 15	MT
Deutsche Bank Adjusts HCA Healthcare Price Target to $359 From $330, Maintains Buy Rating	Apr. 12	MT
Wells Fargo Raises Price Target on HCA Healthcare to $315 From $303, Maintains Equalweight Rating	Mar. 28	MT
ANALYST RECOMMENDATIONS : Nasdaq, Stellantis, Clorox, Ulta Beauty, Standard Chartered...	Mar. 26
Hca Healthcare Insider Sold Shares Worth $400,057, According to a Recent SEC Filing	Mar. 21	MT
ANALYST RECOMMENDATIONS : Doordash, Microsoft, Roblox, Uber, Redrow...	Feb. 08
UBS Adjusts HCA Healthcare Price Target to $348 From $305, Maintains Buy Rating	Jan. 31	MT
Deutsche Bank Raises HCA Healthcare Price Target to $330 From $280, Maintains Buy Rating	Jan. 31	MT
Raymond James Raises Price Target on HCA Healthcare to $330 From $300, Maintains Outperform Rating	Jan. 31	MT
Oppenheimer Raises HCA Healthcare Price Target to $330 From $315, Maintains Outperform Rating	Jan. 31	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

339.8 USD

Average target price

348.7 USD

Spread / Average Target

+2.63%

High Price Target

396 USD

Spread / Highest target

+16.56%

Low Price Target

285 USD

Spread / Lowest Target

-16.11%

Consensus detail

Consensus revision (last 18 months)

Analysts covering HCA Healthcare, Inc.

Goldman Sachs
JPMorgan Chase
Baird
UBS
DBS Bank
TD Cowen
Leerink Partners
RBC Capital Markets
Oppenheimer
Barclays
Mizuho Securities
Truist Securities
Deutsche Bank Securities
Wells Fargo Securities
Raymond James
Bernstein
Argus
Stephens Inc.
Baptista Research
Credit Suisse
Jefferies & Co.
Citigroup
BofA Securities
Loop Capital
Cantor Fitzgerald
Cowen
SVB Securities LLC
BMO Capital
SVB Leerink
Seaport Global Securities

Ratings for HCA Healthcare, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar